Hugo O. Besedovsky

Marburg An Der Lahn, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Evolution Has neither Goals nor Aims, Only Needs.

Evolution Has neither Goals nor Aims, Only Needs.

Journal: Neuroimmunomodulation

Published: October 12, 2025

Combined Use of Intranasal Methylprednisolone and Allopregnanolone: Revisiting Anti-inflammatory and Remyelinating Treatment in a Murine Model of Multiple Sclerosis.

Combined Use of Intranasal Methylprednisolone and Allopregnanolone: Revisiting Anti-inflammatory and Remyelinating Treatment in a Murine Model of Multiple Sclerosis.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 20, 2024

A Glucocorticoid-Mediated Immunoregulatory Circuit Integrated at Brain Levels: Our Early Studies and a Present View.

A Glucocorticoid-Mediated Immunoregulatory Circuit Integrated at Brain Levels: Our Early Studies and a Present View.

Journal: Neuroimmunomodulation

Published: July 11, 2024

Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial.

Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial.

Journal: Archives of medical research

Published: July 15, 2023

Sympathetic-Immune Interactions during Different Types of Immune Challenge.

Sympathetic-Immune Interactions during Different Types of Immune Challenge.

Journal: Neuroimmunomodulation

Published: May 31, 2023

The immune system tends to eliminate the host when it cannot control pathogenic threats: Evolutionary, medical, and epidemiologic perspectives.

The immune system tends to eliminate the host when it cannot control pathogenic threats: Evolutionary, medical, and epidemiologic perspectives.

Journal: Brain, behavior, and immunity

Published: December 30, 2022

To protect or to kill: A persisting Darwinian immune dilemma.

To protect or to kill: A persisting Darwinian immune dilemma.

Journal: Brain, behavior, and immunity

Published: January 18, 2022

Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.

Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.

Journal: Trials

Published: July 10, 2021

Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in Mice.

Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in Mice.

Journal: The Journal of pharmacology and experimental therapeutics

Published: January 20, 2021

Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model.

Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: July 08, 2020

Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis.

Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis.

Journal: Journal of neuropathology and experimental neurology

Published: July 30, 2019

Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury.

Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury.

Journal: Annals of the New York Academy of Sciences

Published: July 26, 2018

Showing 1-12 of 41

Last Updated: 09/26/2026